Clinical Research Directory
Browse clinical research sites, groups, and studies.
Tofacitinib in Juvenile Idiopathic Arthritis
Sponsor: Consorci Sanitari de l'Alt Penedès i Garraf
Summary
This study aims to evaluate, using real-world clinical practice data, the efficacy of tofacitinib in improving the clinical control of juvenile idiopathic arthritis (JIA) after 12 months of treatment.
Official title: Efficacy of Tofacitinib in Patients With Juvenile Idiopathic Arthritis: A Study Based on Real-world Clinical Practice Data.
Key Details
Gender
All
Age Range
Any - 18 Years
Study Type
OBSERVATIONAL
Enrollment
58
Start Date
2026-02-02
Completion Date
2027-12
Last Updated
2026-10-28
Healthy Volunteers
No
Conditions
Interventions
Tofacitinib
Patients received tofacitinib for the treatment of juvenile idiopathic arthritis (JIA).
Locations (7)
Hospital Universitario de A Coruña
A Coruña, A Coruña, Spain
Hospital Universitari Germans Trias i Pujol
Badalona, Barcelona, Spain
Hospital Sant Joan de Déu Barcelona
Barcelona, Barcelona, Spain
Althaia Xarxa Assistencial Universitaria de Manresa
Manresa, Barcelona, Spain
Corporació Sanitària Parc Taulí de Sabadell
Sabadell, Barcelona, Spain
Hospital de Vilafranca
Vilafranca del Penedès, Barceona, Spain
Hospital Santa Cristina de Madrid
Madrid, Madrid, Spain